Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Nathan

Showing results (81-90 of 420) with videos related to

Pageof 42
Sort By:
Genome Medicine|June 13, 2009
Musings on genome medicine: cholesterol and coronary artery diseaseDavid G Nathan, Stuart H Orkin
Genome Medicine|March 3, 2010
Musings on genome medicine: Hepatitis CDavid G Nathan, Stuart H Orkin
Clinics in Haematology|February 1, 1975
Haemolysis due to pyruvate kinase deficiency and other glycolytic enzymopathiesB E Glader, D G Nathan
The New England Journal of Medicine|January 2, 1975
Frederick Stohlman, Jr., M.DW C Moloney, D G Nathan
The New England Journal of Medicine|September 23, 1976
The thalassemiasS H Orkin, D G Nathan
Blood|May 1, 1978
Cation permeability alterations during sickling: relationship to cation composition and cellular hydration of irreversibly sickled cellsB E Glader, D G Nathan
Genome Medicine|November 7, 2009
Musings on genome medicine: Crohn's diseaseDavid G Nathan, Stuart H Orkin
The American Journal of Psychiatry|April 1, 1985
Long-term dependence on antidepressantsR G Nathan, J L Kinney
Progress in Hematology|January 1, 1987
The biological activities and uses of recombinant granulocyte-macrophage and multi-colony stimulating factorsD G Nathan, C A Sieff
Genome Medicine|December 19, 2009
Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseasesDavid G Nathan, Stuart H Orkin
Pageof 42

Showing results (81-90 of 420) with videos related to

Sort By:
Pageof 42
Genome Medicine|June 13, 2009
Musings on genome medicine: cholesterol and coronary artery diseaseDavid G Nathan, Stuart H Orkin
Genome Medicine|March 3, 2010
Musings on genome medicine: Hepatitis CDavid G Nathan, Stuart H Orkin
Clinics in Haematology|February 1, 1975
Haemolysis due to pyruvate kinase deficiency and other glycolytic enzymopathiesB E Glader, D G Nathan
The New England Journal of Medicine|January 2, 1975
Frederick Stohlman, Jr., M.DW C Moloney, D G Nathan
The New England Journal of Medicine|September 23, 1976
The thalassemiasS H Orkin, D G Nathan
Blood|May 1, 1978
Cation permeability alterations during sickling: relationship to cation composition and cellular hydration of irreversibly sickled cellsB E Glader, D G Nathan
Genome Medicine|November 7, 2009
Musings on genome medicine: Crohn's diseaseDavid G Nathan, Stuart H Orkin
The American Journal of Psychiatry|April 1, 1985
Long-term dependence on antidepressantsR G Nathan, J L Kinney
Progress in Hematology|January 1, 1987
The biological activities and uses of recombinant granulocyte-macrophage and multi-colony stimulating factorsD G Nathan, C A Sieff
Genome Medicine|December 19, 2009
Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseasesDavid G Nathan, Stuart H Orkin
Pageof 42